Navigation Links
Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study
Date:11/9/2009

HOPKINTON, Mass., Nov. 9 /PRNewswire/ -- Facet Solutions, Inc. today announced that it has enrolled the 100th patient in its randomized, controlled ACADIA(TM) IDE study for lumbar spinal stenosis. "We are well ahead of our projections for 2009," stated President and CEO, Geoff Pardo. "It is indicative of the market need, the clinical outcomes that surgeons are seeing, and the ease with which they can implant ACADIA(TM)." Over 1.5 million people are diagnosed with lumbar spinal stenosis each year in the United States. Current treatment alternatives include fusion, which eliminates motion and can result in long recovery for patients.

Dr. Jim Youssef, orthopedic spine surgeon of SpineColorado in Durango, CO, remarked, "We are excited to be a part of this landmark study. Spinal stenosis is a common indication that I see in my practice, and the ability to offer patients a complete decompression while restoring motion and stability, is a very compelling proposition for both patient and surgeon."

Dr. Darryl DiRisio, neurosurgeon at Albany Medical Center in Albany, NY, added, "ACADIA(TM) is an easy to use system that has a minimal learning curve and fits into my surgical practice. What is exciting for these stenosis patients, in addition to the pain relief, is the potential for a quicker recovery over a traditional fusion."

Facet Solutions, Inc. has developed ACADIA(TM) to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The ACADIA(TM) procedure includes replacement of the diseased posterior spinal joints with an anatomic implant that is designed to restore the natural motion, stability, and balance to the lumbar spine.

Dr. Antonio Castellvi will be presenting a worldwide clinical update at the upcoming North American Spine Society meeting in San Francisco, CA on November 10th at 10:15am in room 300.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is certified to ISO 13485. ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

SOURCE Facet Solutions, Inc.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. First Human Implant of New Archus Orthopedics Facet Replacement System
4. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
5. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
6. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
7. DATATRAK eClinical(TM) Supports Multifaceted Studies
8. Facet Solutions Acquires Archus Orthopedics
9. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
10. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
11. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... The global prefilled syringes market accounted for $3,905.1 million ... with a CAGR of 12.9% during 2015-2020. Among the ... global prefilled syringes market, with 90.1% share in 2014. ... global market of prefilled syringes is up surging with ... demand for vaccines, increasing prevalence of chronic and lifestyle ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength of traditional ... ensures the integrity of biological samples while operating at ultra-high pressures of 20,000 ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over steep cost increases ... D a decade ago, according to The Senior Citizens League (TSCL). ... are coping with rapidly rising costs. “The implications are chilling, particularly for people ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... concussion, yet the cause of injury may be one of many possible sources: ... PT Continuing Education Course , Mastering Rehab Solutions for the Complexities ...
(Date:2/9/2016)... ... February 09, 2016 , ... February is Heart Awareness Month, and ... scans throughout the month to the American Heart Association, New Mexico chapter. , A ... heart disease and Health Quest’s INSiGHT Pulse Wave Profiler utilizes a non-invasive technology to ...
Breaking Medicine News(10 mins):